Conference Coverage

End-stage renal disease risk in lupus nephritis remains unchanged of late


 

FROM ARTHRITIS & RHEUMATOLOGY

References

The study was supported by the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The authors reported having no conflicts of interest.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

ACR: Don’t give pneumococcal vaccine to CAPS, Behçet’s patients
MDedge Internal Medicine
ACR: Cryoglobulinemic vasculitis in Sjögren’s linked to lymphoma, mortality
MDedge Internal Medicine
Steroid use down, biologic use rising in pregnancies of women with rheumatic disease
MDedge Internal Medicine
Second dose of herpes zoster vaccine beneficial to seniors
MDedge Internal Medicine
FDA approves selexipag for pulmonary arterial hypertension
MDedge Internal Medicine
ACR: Actual-weight hydroxychloroquine dosing works in SLE, up to a point
MDedge Internal Medicine
ACR: VEBs predict sudden cardiac death in systemic sclerosis
MDedge Internal Medicine
ACR: First U.S. clinical practice guidelines arise for Sjögren’s syndrome management
MDedge Internal Medicine
EADV: DLX105 is a novel treatment strategy for Behçet’s flares
MDedge Internal Medicine
Axis I psychiatric disorders high in skin-restricted lupus patients
MDedge Internal Medicine